David Shaw’s Medifast MED Stock Holding History

David Shaw’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-72,700	Closed	-$741K	–	5081
2026 Q1	$741K	Buy	+72,700	New	+$784K	﹤0.01%	3618
2025 Q4	–	Sell	-16,700	Closed	-$228K	–	4848
2025 Q3	$228K	Hold	16,700	–	–	﹤0.01%	4230
2025 Q2	$235K	Buy	+16,700	New	+$219K	﹤0.01%	3991
2025 Q1	–	Sell	-10,700	Closed	-$189K	–	4542
2024 Q4	$189K	Sell	10,700 -50,500	-83%	-$937K	﹤0.01%	4099
2024 Q3	$1.17M	Buy	61,200 +40,000	+189%	+$771K	﹤0.01%	3156
2024 Q2	$463K	Sell	21,200 -22,200	-51%	-$592K	﹤0.01%	3667
2024 Q1	$1.66M	Buy	+43,400	New	+$2.1M	﹤0.01%	2764
2021 Q2	–	Sell	-5,400	Closed	-$1.14M	–	4903
2021 Q1	$1.14M	Hold	5,400	–	–	﹤0.01%	3016
2020 Q4	$1.06M	Sell	5,400 -11,000	-67%	-$1.94M	﹤0.01%	2980
2020 Q3	$2.7M	Buy	+16,400	New	+$2.7M	﹤0.01%	2167
2020 Q2	–	Sell	-10,000	Closed	-$625K	–	4154
2020 Q1	$625K	Sell	10,000 -8,300	-45%	-$756K	﹤0.01%	3081
2019 Q4	$2M	Buy	18,300 +10,000	+120%	+$968K	﹤0.01%	2475
2019 Q3	$860K	Buy	+8,300	New	+$892K	﹤0.01%	2912
2019 Q1	–	Sell	-10,000	Closed	-$1.25M	–	3786
2018 Q4	$1.25M	Sell	10,000 -20,000	-67%	-$3.42M	﹤0.01%	2505
2018 Q3	$6.65M	Buy	30,000 +15,000	+100%	+$3.04M	0.01%	1380
2018 Q2	$2.4M	Buy	15,000 +5,000	+50%	+$639K	﹤0.01%	2095
2018 Q1	$935K	Sell	10,000 -600	-6%	-$44.8K	﹤0.01%	2531
2017 Q4	$740K	Buy	+10,600	New	+$703K	﹤0.01%	2749
2014 Q4	–	Sell	-21,900	Closed	-$719K	–	4152
2014 Q3	$719K	Hold	21,900	–	–	﹤0.01%	3080
2014 Q2	$666K	Buy	+21,900	New	+$682K	﹤0.01%	3283

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

David Shaw's MED Position: Q2 2026 in Review

David Shaw reduced its Medifast (MED) stake by 42% in Q2 2026, selling an estimated $787K and leaving 92,345 shares worth $980K. The position accounts for ﹤0.01% of the portfolio, ranked #3762.

David Shaw first reported a position in MED in Q1 2014 and has held it in 37 quarters since. The position peaked at $8.93M in Q1 2023. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

David Shaw held 92,345 shares of Medifast worth $980K as of Q2 2026.
David Shaw sold 68,219 Medifast shares in Q2 2026, an estimated $787K.
Medifast made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3762 holding.
David Shaw first reported a position in Medifast in Q1 2014 and has held it in 37 quarters since.
David Shaw's Medifast position peaked at $8.93M in Q1 2023.
112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.